Google+ Facebook Twitter Twitter

Urgent need for early COVID-19 treatments

COVID-19 treatments for people with early infection are needed urgently, according to Anthony S Fauci, Director of the US National Institute of Allergy and Infectious Diseases.

Treating people early in the course of infection with SARS-CoV-2 would speed their recovery, reduce the likelihood that they develop severe outcomes and reduce demand on the healthcare system, Fauci and colleagues wrote in JAMA.

Despite experiencing only mild symptoms early in infection, many COVID-19 patients progress to severe disease that leads to hospitalisation. Some also will experience lengthy recoveries and develop long-lasting fatigue, mental impairment and problems with heart and lung function.

While several treatments, such as remdesivir and dexamethasone, are available, or are in development, that can be administered early during the course of infection to prevent disease progression and longer-term complications, more are urgently needed, they write.

Image Credit: iStock

Related Articles

The vaccine race

With more than 150 COVID-19 vaccines in development, we put the three front-runners under the microscope and look at the incredible, unprecedented development work of the last year.

Smallpox, salmonella and sacrifice

Stephen Mortlock looks back at the history of the Aztec civilisation, the diseases that struck and the treatments that were created.

What is long COVID?

Dr David Strain, a Senior Clinical Lecturer, is heading up the British Medical Association’s work on the long-term impact of COVID-19. Here he explains what we know so far about long COVID.

New biomarker to prevent graft-versus-host disease

A recent report sheds light on immune cell biomarkers that may reveal which patients are most at risk for graft-versus-host disease (GVHD).